Further characterization of αN-acetyl β-endorphin-(1–31) regulatory activity, I: Effect on opioid- and α2-mediated supraspinal antinociception in mice
- 31 December 1992
- journal article
- Published by Elsevier in Life Sciences
- Vol. 50 (26) , 2083-2097
- https://doi.org/10.1016/0024-3205(92)90575-a
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- αN-acetyl derivatives of β-endorphin-(1–31) and -(1–27) regulate the supraspinal antinociceptive activity of different opioids in miceLife Sciences, 1991
- G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptidesTrends in Pharmacological Sciences, 1990
- Intracerebroventricular N-ethylmaleimide differentially reduces supraspinal opioid analgesia in miceEuropean Journal of Pharmacology, 1989
- Evaluation of δ receptor mediation of supraspinal opioid analgesia by in vivo protection against the β-funaltrexamine antagonist effectEuropean Journal of Pharmacology, 1989
- Adenylate cyclase supersensitivity: a general means of cellular adaptation to inhibitory agonists?Trends in Pharmacological Sciences, 1987
- G Proteins: A Family of Signal TransducersAnnual Review of Cell Biology, 1986
- Opioid receptor types and membrane ion channelsTrends in Neurosciences, 1986
- Influence of N-terminal acetylation and C-terminal proteolysis on the analgesic activity of β-endorphinBiochemical Journal, 1980
- Endorphins are stored in biologically active and inactive forms: isolation of α-N-acetyl peptidesNature, 1979
- Enzyme changes in neonatal skeletal muscle: effect of thyroid deficiencyAmerican Journal of Physiology-Cell Physiology, 1978